2nd Int HepCure meeting – presentations

 
The Toronto Declaration - Where are we now?
Dr. Jordan Feld, MD - University Hospital Toronto, Canada
 Session 1: Hepatitis Vaccines; What does the Future hold?
 
Hepatitis C Vaccines: Are we making progress?
Dr. Christopher Walker, PhD - The Research Institute at Nationwide Children’s Hospital, Ohio, USA
 
A hepatitis C Vaccine: How do we prove it works?
Dr. Kim Page, PhD, MPH, MS - UCSF School of Medicine, USA
 
Hepatitis B Vaccine: Optimizing coverage and efficacy
Dr. Alex Vorsters, Ir, MSc - University of Antwerp, Belgium
 Session 2: Testing Strategies for at Risk Populations
 
Point-of-care (POC) testing in Hepatitis B and C
Dr. Scott Bowden, PhD - The Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
 
Baby Boomer Screening in the U.S: Delivering on the promise thus far?
Dr. John Ward, MD - Centers for Disease Control and Prevention, USA
 
New tools for testing and monitoring Hepatitis B and C
Dr. Stephen Locarnini, BSc, PhD, MBBS, FRC - Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia
 Session 3: Optimizing Treatment in Hepatitis B and C
 
New Treatment Strategies for Hepatitis B
Dr. Harry Janssen, MD, PhD - University Hospital Toronto, Canada
 
Maximizing SVR with current HCV therapy
Dr. Alnoor Ramji, MD, FRCP - University Of British Columbia, Canada
 
New Treatment in HCV: Is there need for more therapies?
Dr. Jordan Feld, MD - University Hospital Toronto, Canada
 Session 4: Access to Care: A Global Perspective
 
Hepatitis C treatment in resource-limited countries
Dr. Manal El-Sayed, MD - Ain Shams University, Egypt
 
Rational pricing and the role of generics
Dr. Ray Schinazi, PhD, DSc - Emory University/VA Medical Center, USA
 Session 5: How to prioritize HCV treatment
 
Perspective from Health Economics
Dr. David Rein, PhD - NORC at the University of Chicago, USA
 
Perspective from Civil Society
Dr. Tracy Swan - Treatment Action Group, USA
 


Perspective from Payers
Dr. Mel Krajden, MD, FRCPC - BC Centre for Disease Control, Canada

 

common_plaguesDr. Bonnie Henry, MD, MPH, FRCPC - MoH British Colombia, Canada

 
Perspective from Medical Community
Dr. Margaret Hellard, MBBS, FRACP, FAFPHM, PhD - Burnet Institute, Australia